Abstract
Key points: Unilateral or destructive sinonasal disease should raise suspicion for tumor. Patients receiving biologic therapy for CRSwNP should be carefully selected. Tissue diagnosis should be considered prior to starting biologics for nasal polyposis.
Original language | English (US) |
---|---|
Pages (from-to) | 1659-1663 |
Number of pages | 5 |
Journal | International Forum of Allergy and Rhinology |
Volume | 14 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2024 |
Keywords
- CRSwNP
- biologic therapy
- chronic rhinosinusitis
- nasal polyposis
- sinonasal tumor
ASJC Scopus subject areas
- Immunology and Allergy
- Otorhinolaryngology